Psoriasis Drug Raptiva Pulled From U.S. Market - Forbes.com

Psoriasis Drug Raptiva Pulled From U.S. Market - Forbes.com: "The troubled psoriasis drug Raptiva is being withdrawn from the U.S. market, California-based drug maker Genentech ( DNA - news - people ) announced Wednesday.

The move comes almost two months after U.S. health officials issued a public health advisory on the drug after confirming a link to a rare, sometimes fatal brain infection." [Forbes]